The current classification system for colorectal cancer, which is based on genetic expression profiles, cannot be used to predict drug responses to FOLFIRI. This is the conclusion reached by a team from the Spanish National ...
Nov 07, 2014
5 / 5 (1) | 0
(HealthDay)—Proton pump inhibitors may disrupt the microbiome of the digestive system, leading to infections and other complications, according to a small new study published online Nov. 25 in Microbiome.
Nov 26, 2014
4 / 5 (1) | 0